Truist Financial’s Columbia Research Enhanced Value ETF REVS Stock Holding History
Bought
Maintained
Sold
Other funds holding REVS
NA
PVI
HGERS
HI
Truist Financial's REVS Position: Q4 2023 in Review
Truist Financial sold out of Columbia Research Enhanced Value ETF (REVS) in Q4 2023, closing a stake of 133,957 shares — an estimated $2.73M sold.
Truist Financial first reported a position in REVS in Q2 2021 and held it in 9 quarters. The position peaked at $2.91M in Q2 2023. 13 funds tracked by Wall St. Rank hold REVS as of Q4 2023.
- Truist Financial reported no remaining Columbia Research Enhanced Value ETF position as of Q4 2023 after selling out during the quarter.
- Truist Financial sold 133,957 Columbia Research Enhanced Value ETF shares in Q4 2023, an estimated $2.73M.
- Truist Financial first reported a position in Columbia Research Enhanced Value ETF in Q2 2021 and held it in 9 quarters.
- Truist Financial's Columbia Research Enhanced Value ETF position peaked at $2.91M in Q2 2023.
- 13 funds tracked by Wall St. Rank held Columbia Research Enhanced Value ETF as of Q4 2023.
Based on Truist Financial's 13F filing for Q4 2023, filed 2 Feb 2024.